נולוג'יקס 250 מ"ג

Država: Izrael

Jezik: hebrejščina

Source: Ministry of Health

Aktivna sestavina:

BELATACEPT 25 MG/ML

Dostopno od:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

Koda artikla:

L04AA28

Farmacevtska oblika:

POWDER FOR CONCENTRATE FOR INFUSION

Pot uporabe:

I.V

Izdeluje:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Terapevtska skupina:

BELATACEPT

Terapevtske indikacije:

Nulojix, in combination with corticosteroids and mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. It is recommended to add an interleukin (IL)-2 receptor antagonist for induction therapy to this belatacept-based regimen

Datum dovoljenje:

2012-08-01